News

Malaria parasites invade human red blood cells, they then disrupt them and infect others. Researchers at the University of Basel and the Swiss Tropical and Public Health Institute have now developed so-called nanomimics of host cell membranes that trick the parasites. This could lead to novel treatment and vaccination strategies in the fight against malaria and other infectious diseases. Their research results have been published in the scientific journal ACS Nano.

FDA Clears the Simplexa Flu A/B and RSV Direct Test to Include Eight Circulating Influenza Viruses

December 9th 2014

WHO Says Scale-up in Effective Malaria Control Dramatically Reduces Deaths

December 9th 2014

Malaria Researchers Use New Genomic Tools to Individualize Parasite Analysis

December 9th 2014

X-rays Show How Flu Antibody Binds to Viruses

December 9th 2014

HHS Secretary Issues Declaration Under PREP Act to Support Development of Ebola Vaccines

December 9th 2014

US Endoscopy Announces Full Market Release of the VIA Bedside Pre-Cleaning Kit

December 9th 2014

Crosstex/SPSmedical Introduces SporView 10 Self-Contained Biological Indicators

December 9th 2014

Healthmark Industries Adds PPE Decals to its Labeling Product Line

December 9th 2014

Tecomet, Inc. Acquires Symmetry Medical OEM Solutions Business

December 9th 2014

News

First Skilled Nursing Facility in Texas to Protect Residents with Xenex Germ-Zapping Robot

Comanche County Memorial Hospital Chooses Spectra254 Ultraviolet Light Systems

Sealed Air Awarded Contract with Premier, Inc., Named Sole Supplier for ASCEND Collaborative

Baylor Research Could Lead to Development of Novel Vaccines from Flu to HIV

Notre Dame Study Examines Important Ebola Protein

How Long Can Ebola Live? Researcher Looks for Answers

Microbiologists Discover How Gut Bacterial Resources are Hijacked to Promote Intestinal Illnesses

Next-Generation Treatment for UTIs May Focus on Fitness Genes

$3.2 Million NIH Grant to Prove Effectiveness of New Treatment for Common HAI

Immunizing Schoolkids Fights Flu in Others, Too

Drug Developed at Pitt Proves Effective Against Antibiotic-Resistant Superbugs

Study Shows Increase in Raw Milk-Associated Outbreaks

Infectious Disease Experts Say Guidelines for Treatment of Ebola Patients are Needed Urgently

University of Kansas Research Team Helps WHO Make Sense of Ebola Response Efforts

Molecular Decoys Help Overcome Drug Resistance

Simeprevir-Based Therapy Offers Patients a Cost-Effective Alternative for Hepatitis C Treatment

APIC is 'United Against the Flu' During National Influenza Vaccination Week

Seasonal Flu Vaccines Boost Immunity to Many Types of Flu Viruses

Nurses Spearhead Quality Initiatives to Reduce Infection Rates, Improve Patient Outcomes

Cepheid Receives FDA Clearance for Xpert Norovirus

Nanotechnology is Used Against Malaria Parasites

FDA Clears the Simplexa Flu A/B and RSV Direct Test to Include Eight Circulating Influenza Viruses

WHO Says Scale-up in Effective Malaria Control Dramatically Reduces Deaths

Malaria Researchers Use New Genomic Tools to Individualize Parasite Analysis

X-rays Show How Flu Antibody Binds to Viruses

HHS Secretary Issues Declaration Under PREP Act to Support Development of Ebola Vaccines

US Endoscopy Announces Full Market Release of the VIA Bedside Pre-Cleaning Kit

Crosstex/SPSmedical Introduces SporView 10 Self-Contained Biological Indicators

Healthmark Industries Adds PPE Decals to its Labeling Product Line

Tecomet, Inc. Acquires Symmetry Medical OEM Solutions Business

Trending on Infection Control Today

Why Visibly Clean Environments Can Still Create Infection Risks

Beyond the Alert: Why Sepsis Outcomes Come Down to What Happens After Detection

The Discipline of Waiting: Uganda's 42-Day Ebola Countdown

Special Feature. Three Days in Cambodia: What a Volunteer Saw Before He Had the Words

FDA Expands Cyclospora Outbreak Investigation to 9 States as Nearly 2,000 Confirmed Cases Highlight Challenges for Health Care Facilities